Mann DL - Search Results

1

Warfarin and aspirin in patients with heart failure and sinus rhythm.

Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R; WARCEF Investigators. Homma S, et al. Among authors: mann dl. N Engl J Med. 2012 May 17;366(20):1859-69. doi: 10.1056/NEJMoa1202299. Epub 2012 May 2. N Engl J Med. 2012. PMID: 22551105 Free PMC article. Clinical Trial.

2

Basic mechanisms in heart failure: the cytokine hypothesis.

Seta Y, Shan K, Bozkurt B, Oral H, Mann DL. Seta Y, et al. Among authors: mann dl. J Card Fail. 1996 Sep;2(3):243-9. doi: 10.1016/s1071-9164(96)80047-9. J Card Fail. 1996. PMID: 8891862 Review.

3

Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure.

Deswal A, Bozkurt B, Seta Y, Parilti-Eiswirth S, Hayes FA, Blosch C, Mann DL. Deswal A, et al. Among authors: mann dl. Circulation. 1999 Jun 29;99(25):3224-6. doi: 10.1161/01.cir.99.25.3224. Circulation. 1999. PMID: 10385494 Clinical Trial.

4

The relationship of the erythrocyte sedimentation rate to inflammatory cytokines and survival in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.

Sharma R, Rauchhaus M, Ponikowski PP, Varney S, Poole-Wilson PA, Mann DL, Coats AJ, Anker SD. Sharma R, et al. Among authors: mann dl. J Am Coll Cardiol. 2000 Aug;36(2):523-8. doi: 10.1016/s0735-1097(00)00745-2. J Am Coll Cardiol. 2000. PMID: 10933367 Free article.

5

Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure.

Torre-Amione G, Young JB, Durand J, Bozkurt B, Mann DL, Kobrin I, Pratt CM. Torre-Amione G, et al. Among authors: mann dl. Circulation. 2001 Feb 20;103(7):973-80. doi: 10.1161/01.cir.103.7.973. Circulation. 2001. PMID: 11181472 Clinical Trial.

6

Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure.

Bozkurt B, Torre-Amione G, Warren MS, Whitmore J, Soran OZ, Feldman AM, Mann DL. Bozkurt B, et al. Among authors: mann dl. Circulation. 2001 Feb 27;103(8):1044-7. doi: 10.1161/01.cir.103.8.1044. Circulation. 2001. PMID: 11222463 Clinical Trial.

7

New therapeutics for chronic heart failure.

Mann DL, Deswal A, Bozkurt B, Torre-Amione G. Mann DL, et al. Annu Rev Med. 2002;53:59-74. doi: 10.1146/annurev.med.53.082901.104004. Annu Rev Med. 2002. PMID: 11818463 Review.

8

Preclinical and clinical assessment of the safety and potential efficacy of thalidomide in heart failure.

Agoston I, Dibbs ZI, Wang F, Muller G, Zeldis JB, Mann DL, Bozkurt B. Agoston I, et al. Among authors: mann dl. J Card Fail. 2002 Oct;8(5):306-14. doi: 10.1054/jcaf.2002.128684. J Card Fail. 2002. PMID: 12411981 Clinical Trial.

9

Use of biomarkers in the management of heart failure: are we there yet?

Bozkurt B, Mann DL. Bozkurt B, et al. Among authors: mann dl. Circulation. 2003 Mar 11;107(9):1231-3. doi: 10.1161/01.cir.0000057608.97285.20. Circulation. 2003. PMID: 12628938 No abstract available.

10

Experimental options in the treatment of heart failure: the role of cytokine antagonism.

Kalra D, Bozkurt B, Deswal A, Torre-Amione G, Mann DL. Kalra D, et al. Among authors: mann dl. Heart Fail Monit. 2001;1(4):114-21. Heart Fail Monit. 2001. PMID: 12634895 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

795 results

Search Page